Dr. Yousef M Hawsawi
Adjunct Assistant Professor /associate scientist
Al-Faisal University / King Faisal Specialist Hospital
Dr. Yousef M Hawsawi is an Adjunct Assistant Professor at Al-Faisal University and an associate scientist at department of genetics at King Faisal Specialist Hospital and Research Center (Gen Org) Riyadh –Saudi Arabia. Dr. Hawsawi is also an associate scientist at King Abdulaziz City for Science and Technology in department of the National Center for genomics Technology, Riyadh –Saudi Arabia. Dr. Hawsawi is a registered scientist by the Royal society of biology (RSci) UK. In 2014, Dr. Hawsawi was awarded the BACR - Hamilton- Fairley Young Investigator Award at the 10th NCRI Cancer Conference held in Liverpool (2-5 Nov 2014). He has been granted a 7 years’ scholarship sponsored by King Faisal specialist hospital & Research Centre and Saudi government. Dr. Hawsawi holds a Bachelor degree of medical technology from King Abdulaziz University, a Master degree with distinction from Bangor University-UK and a PhD degree from Leeds University UK. After being granted a PhD from the University of Leeds, Dr. Hawsawi completed a Postdoctoral Fellow at MD Anderson Cancer Center, the top prestigious institute in the world, at the department of Breast Medical Oncology with the group of tamoxifen under the supervision of Prof Craig Jordan (The Father of Tamoxifen) (United states). He has published 12 papers in journals, conference proceedings. He has participated in the scientific committee of several conferences and associations. He is a member in several professional organizations including, American Association for Chemistry (AACC), Stonebridge associated colleges (S.A.C Dip), Associate Member of Cell Biology (AMSB), American Association for Cancer Research (AACR), European Association for Cancer Research (EACR), British Association for Cancer Research (BACR), National Postdoctoral Association (Jan 2016) and Genetics Society of America (Jan 2016).
Characterization of molecular genetics basis of breast and prostate cancer